These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 38612766)

  • 21. Merkel Cell Polyomavirus Small T Antigen Drives Cell Motility via Rho-GTPase-Induced Filopodium Formation.
    Stakaitytė G; Nwogu N; Dobson SJ; Knight LM; Wasson CW; Salguero FJ; Blackbourn DJ; Blair GE; Mankouri J; Macdonald A; Whitehouse A
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
    Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cdc42-mediated supracellular cytoskeleton induced cancer cell migration under low shear stress.
    Liu L; Jiang H; Zhao W; Meng Y; Li J; Huang T; Sun J
    Biochem Biophys Res Commun; 2019 Oct; 519(1):134-140. PubMed ID: 31477271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
    Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
    FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-543 inhibits the proliferation, migration, invasion, and epithelial-mesenchymal transition of triple-negative breast cancer cells via down-regulation of ACTL6A gene.
    Wang YL; Liang RH; Wang CY; Zhang RP; Wu SY; Han X; Zhang GL
    Clin Transl Oncol; 2022 Jan; 24(1):84-92. PubMed ID: 34181232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Rac and Cdc42 Inhibitor MBQ-167 in Triple-negative Breast Cancer.
    Cruz-Collazo A; Ruiz-Calderon JF; Picon H; Borrero-Garcia LD; Lopez I; Castillo-Pichardo L; Del Mar Maldonado M; Duconge J; Medina JI; Bayro MJ; Hernández-O'Farrill E; Vlaar CP; Dharmawardhane S
    Mol Cancer Ther; 2021 Dec; 20(12):2420-2432. PubMed ID: 34607932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer.
    Perez Kerkvliet C; Dwyer AR; Diep CH; Oakley RH; Liddle C; Cidlowski JA; Lange CA
    Breast Cancer Res; 2020 May; 22(1):39. PubMed ID: 32357907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-canonical Notch Signaling Regulates Actin Remodeling in Cell Migration by Activating PI3K/AKT/Cdc42 Pathway.
    Liu L; Zhang L; Zhao S; Zhao XY; Min PX; Ma YD; Wang YY; Chen Y; Tang SJ; Zhang YJ; Du J; Gu L
    Front Pharmacol; 2019; 10():370. PubMed ID: 31057403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRSp53 coordinates AMPK and 14-3-3 signaling to regulate filopodia dynamics and directed cell migration.
    Kast DJ; Dominguez R
    Mol Biol Cell; 2019 May; 30(11):1285-1297. PubMed ID: 30893014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The roles of Cdc42 and Rac1 in the formation of plasma membrane protrusions in cancer epithelial HeLa cells.
    Ruiz-Lafuente N; Minguela A; Muro M; Parrado A
    Mol Biol Rep; 2021 May; 48(5):4285-4294. PubMed ID: 34110575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Icariin Induces Triple-Negative Breast Cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-Jun Signaling Pathway.
    Gao S; Zhang X; Liu J; Ji F; Zhang Z; Meng Q; Zhang Q; Han X; Wu H; Yin Y; Lv Y; Shi W
    Drug Des Devel Ther; 2023; 17():821-836. PubMed ID: 36969705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
    Jin XX; Mei YN; Shen Z; Zhu JF; Xing SH; Yang HM; Liang G; Zheng XH
    Phytomedicine; 2022 Jul; 101():154087. PubMed ID: 35429924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ERK3/MAPK6 dictates CDC42/RAC1 activity and ARP2/3-dependent actin polymerization.
    Bogucka-Janczi K; Harms G; Coissieux MM; Bentires-Alj M; Thiede B; Rajalingam K
    Elife; 2023 Apr; 12():. PubMed ID: 37057894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The netrin-1 receptor DCC promotes filopodia formation and cell spreading by activating Cdc42 and Rac1.
    Shekarabi M; Kennedy TE
    Mol Cell Neurosci; 2002 Jan; 19(1):1-17. PubMed ID: 11817894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1α.
    Qiu J; Shen Z; Jiang G; Ni Q
    Anticancer Agents Med Chem; 2023; 23(4):470-477. PubMed ID: 35980070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
    Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
    J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation.
    Marivin A; Berthelet J; Cartier J; Paul C; Gemble S; Morizot A; Boireau W; Saleh M; Bertoglio J; Solary E; Dubrez L
    Oncogene; 2014 Nov; 33(48):5534-45. PubMed ID: 24276241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer.
    Tan Z; Deme P; Boyapati K; Claes BSR; Duivenvoorden AAM; Heeren RMA; Tressler CM; Haughey NJ; Glunde K
    Breast Cancer Res; 2023 Nov; 25(1):148. PubMed ID: 38017485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.